BioCardia, Inc.

US$0.85As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BCDAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (43.53%)
Div yield —
ROE (1803.19%)
Biotechnology
Beta (5Y) 0.65
PE TTM —
TSR TTM (39.29%)
Mkt cap US$12.87M
ROIC (498.78%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.831
(2.22%)
(20.08%)
Hold 3|10|10|9|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
29.73%
14.09%
5.66%
(4.02%)
Revenue$M
0.974
1.002
1.020
1.021
(0.21%)
1.90%
4.22%
5.75%
Peers (US$12.87M)
Cap (US$)
PE
12.94M
—
12.79M
—
Capital
TTM
5Y
10Y
Leveragex
1.818
0.055
0.052
EBIT/Intx
0.734
0.315
0.333
Own earn%
(23.17)
(57.63)
(47.18)
Sh yield%
36.81
51.60
50.08
Owners
Insiders/Inst%
9.78
43.98
Short interest%
5.78
SBC / revenue%
4.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
22–32
$1 testx
−0.2
Incr. ROIC%
4